Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. Gualano, R. Mancini, M. Sane Schepisi, T. Jefferson, F. N. Lauria, E. Girardi (Rome, Anguillara Sabazia, Rome, Italy). Is there enough evidence to support recommendations on tuberculosis control?. Eur Respir J 2008; 32: Suppl. 52, 1595

Member's Comments

No comment yet.

Related content which might interest you: WHO 2019 guidelines on drug-resistant tuberculosis treatment: based on evidence or expert opinion? Source: Eur Respir J, 55 (3) 1901935; 10.1183/13993003.01935-2019 Year: 2020 Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 Key role of tuberculosis services funding mechanisms in tuberculosis control and elimination Source: Eur Respir J 2015; 45: 289-291 Year: 2015 WHO guidance on multidrug-resistant tuberculosis treatment: using and communicating the evidence Source: Eur Respir J, 55 (3) 1902325; 10.1183/13993003.02325-2019 Year: 2020 TB "cross-border" - a new challenge in tuberculosis management Source: Virtual Congress 2020 – Tuberculosis and society Year: 2020 Where we stand according to WHO indicators for tuberculosis control? Source: Annual Congress 2003 - Control of tuberculosis Year: 2003 What next? Basic research, new treatments and a patient-centred approach in controlling tuberculosis Source: Eur Respir Monogr 2018; 82: 414-429 Year: 2018 Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion Source: Eur Respir J 2015; 45: 1170-1173 Year: 2015 Comparison of the treatment guidelines for sarcoidosis: common sense in the search for evidence Source: Eur Respir J, 59 (2) 2103114; 10.1183/13993003.03114-2021 Year: 2022 Good news about a bad subject: scientific evidence to help defeat multidrug/extensively drug-resistant tuberculosis Source: Eur Respir J 2014; 44: 5-7 Year: 2014 Describing what evidence and outcomes to use in guidelines Source: Annual Congress 2008 - Guideline development workshop summary: ATS/ERS integrating and coordinating efforts in COPD Year: 2008 Rethinking the way we are treating established airway disease: current guidelines need to change  Source: International Congress 2016 – Presentation and discussion of a draft Lancet Commission on Asthma Year: 2016 Getting the best possible evidence from observational studies of treatment of multidrug-resistant tuberculosis patients Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013 The concept of control in COPD: a new proposal for optimising therapy Source: Eur Respir J 2014; 44: 1072-1075 Year: 2014 Childhood tuberculosis: progress requires an advocacy strategy now Source: Eur Respir J 2012; 40: 294-297 Year: 2012 A UK population perspective - active intervention and evidence based advice can improve symptom control in asthma Source: Annual Congress 2004 - Primary care: asthma Year: 2004 Failure to interpret evidence on efficacy of neonatal respiratory support strategies? Source: Eur Respir J 2006; 28: Suppl. 50, 490s Year: 2006